fda warning letters glp-1 october 2025 news Last month, the issued 25 to telehealth companies over what it called false or misleading claims about compounded medications Beyond the Headlines: FDA Warning

The Maurten Tour Pack is a curated collection of Maurten's core fueling formats for cyclists who want to build a complete Maurten system before committing to full quantities of each product

Glutathione neutralizes those antioxidants and fights inflammation to reduce damage

Touted as game-changers for weight loss, drugs like Ozempic, Wegovy, Mounjaro and Zepbound are getting attention far beyond diabetes care

Inhibiting the release of glucagon by the pancreas

Retatrutide is the drug of the future Drug maker Eli Lilly has released sneak-peek findings from the Phase 3 trial, and retatrutide benefits seem wildly impressive so far

We aimed to investigate whether GLP-1 RA use would be associated with a reduced risk of legal blindness and ischemic optic neuropathy due to GLP-1 RAs vascular and potential neuroprotective effects